JPRN-jRCT2080221237未知2 期
A Pharmacokinetic Study of TS-071 in Type 2 Diabetes Mellitus Patients With Renal Dysfunction
Taisho Pharmaceutical co., LTD0 个研究点目标入组 50 人开始时间: 2010年9月10日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 79age old（—）
- 性别
- All
入选标准
- •- Type 2 diabetes mellitus patient
排除标准
- •- Non-type 2 diabetes mellitus
- •- Having critical heart disease, other ciruculatory disease, cerebrovascular disorder, pancreatic disease and hematologic disease
研究者
相似试验
未知
3 期
Phase3 Study of TS-071 in Patients With Type 2 Diabetes Mellitus (Double-blind, Parallel Group,Placebo-Controlled Study)Type 2 Diabetes MellitusJPRN-jRCT2080221620Taisho Pharmaceutical co., LTD132
未知
Unknown
A Long-Term Clinical Study of TS-071 in Type 2 Diabetes Mellitus Patients With Renal DysfunctioType 2 Diabetes Mellitus with Renal DysfunctionJPRN-jRCT2080221504Taisho Pharmaceutical co., LTD150
尚未招募
不适用
Een onderzoek naar de opname, verdeling en uitscheiding van bedaquiline, een geneesmiddel tegen tuberculose, in mensen met type II diabetestype 2 diabetes mellitustuberculosisbedaquilinecomorbiditydrug resistanceNL-OMON26912niversity Medical Center Groningen36
未知
4 期
Clinical Pharmaclogical study of TS-071 in Patient With Type 2 Diabetetes Mellitus(Evaluation of glycemic variability using continuous glucose monitoring)Type 2 Diabetes MellitusJPRN-jRCT1080222497Taisho Pharmaceutical co., LTD40
进行中（未招募）
1 期
A pharmacokinetic study of TS-142 in patients with hepatic impairmentInsomniaJPRN-jRCT2031220463Mita Seiji24